Pricing Log in Create free account

Cencora, Inc. (COR) vs Cellyan Biotechnology Co., Ltd (HKPD)

Cencora, Inc. and Cellyan Biotechnology Co., Ltd are both Medical Distribution companies. Cencora, Inc. is the larger, with a market value of $65.2B against $17.1M — 3807.7× the size. Across the 9 metrics below, Cencora, Inc. leads on 6 and Cellyan Biotechnology Co., Ltd on 3.

Valuation

Metric COR HKPD Medical Distribution median
P/E 25.20 — —
P/S 0.20 — 0.27
P/B 20.31 n/m —
Price to free cash flow 16.03 n/m —
EV/EBITDA 18.17 n/m 17.78
EV/Sales 0.22 n/m 0.63
Earnings yield 3.97% — (6.67%)
Free cash flow yield 6.24% 0.00% 0.00%

Profitability

Metric COR HKPD Medical Distribution median
Gross margin 3.97% — 8.01%
Operating margin 0.91% — 0.46%
Net margin 0.79% — (6.08%)
Free cash flow margin 1.23% 0.00% 0.00%
Return on equity 96.34% 0.00% 0.00%
Return on assets 3.33% 0.00% 0.00%
Return on invested capital 15.65% 0.00% 0.00%

Growth

Metric COR HKPD Medical Distribution median
Revenue growth (TTM) 5.09% — 11.54%
EPS growth (last fiscal year) 5.71% (2,492.59%) 5.71%
Revenue growth, 5-year CAGR 11.09% — 8.18%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric COR HKPD Medical Distribution median
Debt to equity 3.62 0.10 (0.34)
Current ratio 0.93 3.86 1.05
Net debt to EBITDA 0.89 (0.79) (0.01)

Dividend

Metric COR HKPD Medical Distribution median
Dividend yield 0.70% — —
Payout ratio 0.18 — —

Size

Metric COR HKPD Medical Distribution median
Market cap 65.15b 17.11m 154.79m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack